Delivery Order SPE2DB22D3004-SPE2DB25FQD46

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.94, is a firm fixed-price delivery order for the supply of IBSRELA 50 MG TABLET UU 60S, a medical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $13,242.25 Delivery Order contract is for the provision of IBSRELA 50 MG TABLET in 60-count units. The contract is a Firm Fixed Price arrangement with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is a Delivery Order valued at $10,091.76 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is with the Defense Logistics Agency (DLA), an agency within the Department of Defense, to provide the pharmaceutical product IBSRELA 50 MG TABLET UU 60S. The contract has an ultimate completion date of November 7, 2024 and utilizes a Firm Fixed Price pricing type. This award is not associated with a set-aside...
This federal contract award to Amerisourcebergen Drug Corporation is for the delivery of IBSRELA 50 MG TABLET in 60-count packages. The Firm Fixed Price (FFP) delivery order, valued at $10,941.12, was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 16, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $35,409.42 firm-fixed-price delivery order is for the pharmaceutical product IBSRELA 50 MG TABLET UU 60S. The contract has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,475.84 firm-fixed-price delivery order is for the pharmaceutical product "IBSRELA 50 MG TABLET UU 60S" and has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with an ID of SPE2DB24D1034|SPE2DB25FWBN7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,137.60 firm fixed-price delivery order contract is for the supply of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product, with a period of performance through March 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,149.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the medical product "IBSRELA 50 MG TABLET UU 60S", with a completion date of March 7, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,122.54 firm fixed-price contract is for the supply of IBSRELA 50 MG TABLET UU 60S medical products. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 24, 2025. This award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,415.48, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, worth $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQD46
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $4,226.33, is for the delivery of IBSRELA 50 MG TABLET medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 7/2/25, 10:45 PM